Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Attention Macrogenics, Inc. (MGNX) Shareholders: Grabar Law Office Investigates Potential Claims on Your Behalf

MGNX

Philadelphia, Pennsylvania--(Newsfile Corp. - November 7, 2024) - Grabar Law Office is actively investigating claims on behalf of MacroGenics, Inc. (NASDAQ: MGNX) shareholders. If you have continuously held MacroGenics stock since before March 7, 2024, you may be entitled to seek corporate reforms, the return of funds to the company, and potentially receive a court-approved incentive award-all at no cost to you. Visit https://grabarlaw.com/the-latest/macrogenics-shareholder-investigation/ or email jgrabar@grabarlaw.com.

What's at Stake?

A recent securities fraud class action claims that MacroGenics, Inc., via certain officers and directors, made misleading statements about the safety data from its TAMARACK Phase 2 study of vobramitamab duocarmazine. When the truth was revealed on May 9, 2024-that the drug was significantly more dangerous than previously represented-the company's stock price plummeted by 77.4%, dropping $11.36 per share, and causing substantial losses for investors.

Your Rights as a Shareholder:

If you are a longer term shareholder MacroGenics shareholder who has held shares since prior to March 7, 2024, this investigation allows you to:

  • Seek corporate governance reforms.
  • Help recover funds for the company.
  • Pursue a court-approved incentive award.

What You Should Do Now:

To learn more about your rights and explore your options or to join at no cost, visit:
https://grabarlaw.com/the-latest/macrogenics-shareholder-investigation/. For immediate assistance, reach out to Joshua H. Grabar at jgrabar@grabarlaw.com or call 267-507-6085.

Protect your investment and demand accountability!

Attorney Advertising Disclaimer

Contact Information:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place, 1650 Market Street, Suite 3600, Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com

#MacroGenicsInvestigation #ShareholderRights #CorporateAccountability #SecuritiesFraud $MGNX #InvestorAlert

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/229261